1. Todoriko LD, Petrenko VI, Denysov OS, Semіaniv IO, Sprynsіan TA, Pidverbetska OV. Severe cases of tuberculosis and substantiation of ways to influence the increase of treatment efficacy according to standard schemes. Tuberculosis, Lung Diseases, HIV-Infection. 2018;33(2): 7–13.
2. Zheng Y, Ma S, Tan D, Lu M. A meta-analysis of liver lesions in hepatitis B patients undergoing antituberculosis therapy. Chinese Journal of Hepatology. 2014;22(8): 585–589.
3. Suriawinata AA, Thung SN. Liver pathology. An Atlas and Concise Guide. New York: Demosmedical; 2011.
4. Galimova SF. Medicinal lesions of the liver. Hepatology. 2012;(3): 38–48.
5. Bushnell G, Stennis NL, Drobnik AM, Proops DC, Ahuja SD, Bornschlegel K, et al. Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000–2010. Epidemiology and Infection. 2015;143(9): 972–981.